Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Print this page Email this page Users Online: 559
Year : 2022  |  Volume : 15  |  Issue : 7  |  Page : 95-96

ELISA IgG versus CMIA IgG for detection of SARS-CoV-2-specific antibodies in COVID-19 patients

1 TWS Center, Bangkok, Thailand
2 Dr. D.Y. Patil University, Pune, Maharashtra, India; Joseph Ayobalola University, Ikeji, Arakeji, Nigeria

Correspondence Address:
Pathum Sookaromdee
TWS Center, Bangkok
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/mjdrdypu.mjdrdypu_226_21

Rights and Permissions

COVID-19 is an important coronavirus infection. The detection of SARS-CoV-2-specific antibodies is important in laboratory medicine. Several serological tests are available. Some serological tests such as ELISA IgG versus CMIA IgG are used as standard references for rapid diagnostic immunoassay. Here, the authors reappraised on the diagnostic property of ELISA IgG versus CMIA IgG for the detection of SARS-CoV-2-specific antibodies in COVID-19 patients. According to the analysis, CMIA IgG has a higher sensitivity and ELISA IgG has a higher specificity. Therefore, CMIA IgG is more appropriate for screening purpose.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded27    
    Comments [Add]    

Recommend this journal